![](https://endpts.com/wp-content/uploads/2021/08/photo_jeffrey-m-goldberg-hires-CA2_1030-1-scaled.jpeg)
Jeffrey Goldberg
Touting CD161 as a test case for single-cell tech, Longwood-backed Immunitas bags $58M for next-gen I/O work
Back when Longwood unveiled its latest immunotherapy startup, Immunitas, the VC’s co-founder Lea Hachigian talked at length about how its single-cell genomics analysis platform could …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.